HomeAWKN • CNSX
add
Awakn Life Sciences Corp
Previous close
$0.095
Year range
$0.060 - $0.23
Market cap
3.96M CAD
Avg Volume
6.03K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Revenue | 3.67K | -87.32% |
Operating expense | 475.50K | -32.44% |
Net income | -376.13K | 41.89% |
Net profit margin | -10.25K | -358.25% |
Earnings per share | — | — |
EBITDA | -467.40K | 30.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 505.85K | -8.80% |
Total assets | 668.81K | -38.68% |
Total liabilities | 2.19M | 7.53% |
Total equity | -1.52M | — |
Shares outstanding | 41.66M | — |
Price to book | -2.38 | — |
Return on assets | -150.55% | — |
Return on capital | 76.45% | — |
Cash Flow
Net change in cash
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Net income | -376.13K | 41.89% |
Cash from operations | -594.87K | 9.17% |
Cash from investing | — | — |
Cash from financing | 392.29K | -48.70% |
Net change in cash | -206.86K | -265.65% |
Free cash flow | -513.64K | -26.84% |
About
Founded
2018
Headquarters
Website
Employees
6
